About Neurolytic Healthcare
Neurolytic Healthcare is a company based in Oxford (United Kingdom) founded in 2019 by Roman Rothaermel and Inna Nicole Thalmann.. Neurolytic Healthcare has raised $3.2 million across 1 funding round from investors including Illumina, Initialized Capital and First In Ventures. The company has 5 employees as of April 30, 2022. Neurolytic Healthcare operates in a competitive market with competitors including Viome, Wysa, Invitae, Color and Everlywell, among others.
- Headquarter Oxford, United Kingdom
- Employees 5 as on 30 Apr, 2022
- Founders Roman Rothaermel, Inna Nicole Thalmann
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Neurolytic Healthcare Ltd
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$3.2 M (USD)
in 1 rounds
-
Latest Funding Round
$3.2 M (USD), Seed
Jul 27, 2022
-
Investors
Illumina
& 5 more
-
Employee Count
5
as on Apr 30, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Neurolytic Healthcare
Neurolytic Healthcare has successfully raised a total of $3.2M through 1 strategic funding round. The most recent funding activity was a Seed round of $3.2 million completed in July 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Seed — $3.2M
-
First Round
First Round
(27 Jul 2022)
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2022 | Amount | Seed - Neurolytic Healthcare | Valuation | Initialized Capital |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Neurolytic Healthcare
Neurolytic Healthcare has secured backing from 6 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include Illumina, Initialized Capital and First In Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Seed and early-stage technology investments are managed by the firm.
|
Founded Year | Domain | Location | |
|
Venture capital firm focused on early-stage biotech companies
|
Founded Year | Domain | Location | |
|
Investments are made in health technology by Arkitekt Ventures.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Neurolytic Healthcare
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Neurolytic Healthcare
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Neurolytic Healthcare Comparisons
Competitors of Neurolytic Healthcare
Neurolytic Healthcare operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Viome, Wysa, Invitae, Color and Everlywell, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Machine learning-based bioinformatics solutions for health insights are provided.
|
|
| domain | founded_year | HQ Location |
AI-driven mental health support platform is provided by Wysa.
|
|
| domain | founded_year | HQ Location |
Home-based genetic tests for detecting diseases are provided to individuals.
|
|
| domain | founded_year | HQ Location |
Cancer care is delivered through a virtual clinic by Color.
|
|
| domain | founded_year | HQ Location |
At-home health tests for biomarkers, nutrition, and hormone analysis.
|
|
| domain | founded_year | HQ Location |
Personalized therapeutics are developed using genomic data for rare diseases.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Neurolytic Healthcare
When was Neurolytic Healthcare founded?
Neurolytic Healthcare was founded in 2019 and raised its 1st funding round 3 years after it was founded.
Where is Neurolytic Healthcare located?
Neurolytic Healthcare is headquartered in Oxford, United Kingdom. It is registered at Oxford, Oxfordshire, United Kingdom.
Who is the current CEO of Neurolytic Healthcare?
Roman Rothaermel is the current CEO of Neurolytic Healthcare. They have also founded this company.
Is Neurolytic Healthcare a funded company?
Neurolytic Healthcare is a funded company, having raised a total of $3.2M across 1 funding round to date. The company's 1st funding round was a Seed of $3.2M, raised on Jul 27, 2022.
How many employees does Neurolytic Healthcare have?
As of Apr 30, 2022, the latest employee count at Neurolytic Healthcare is 5.
What does Neurolytic Healthcare do?
Neurolytic Healthcare was founded in 2019 in Oxford, United Kingdom, within the healthcare sector. Focus is placed on developing smart medical devices aimed at enhancing treatments for neurological disorders. Genomically-driven products are provided, such as a diagnostic support tool, a pharmacogenetic test, and a mobile app for predicting migraine events. Real-time data and genetics from affected individuals are utilized by the app to deliver physiology-specific treatment alerts.
Who are the top competitors of Neurolytic Healthcare?
Neurolytic Healthcare's top competitors include Viome, Wysa and Variant Bio.
Who are Neurolytic Healthcare's investors?
Neurolytic Healthcare has 6 investors. Key investors include Illumina, Initialized Capital, First In Ventures, Arkitekt Ventures, and Y Combinator.